Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
25 Leser
Artikel bewerten:
(0)

Drug Discovery Technologies - A Global Market Overview

DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Drug Discovery Technologies - A Global Market Overview" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening.

Worldwide market for drug discovery technologies explored in this study includes Bioanalytical Assays, Bioinformatics, Cell Based Assays, Genomic Technologies, High Throughput Screening, Proteomic Technologies and Others comprising Epigenetics, Metabolomics, Combinatorial Chemistry, Synthetic Biology, Systems Biology and Nanotechnology.

The global market value for the above mentioned technologies is analyzed in USD. High Throughput Screening accounts for a lion's share in global drug discovery technologies market with an expected share of about 30% in 2015 valued at $18 billion followed by Bioanalytical Assays or instruments by about $14 billion.

This 248 pages global market report includes 28 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 56 key global players and 67 major players across the United States - 41; Europe - 16; Asia-Pacific - 7; and Rest of World - 3. The research also provides the listing of the companies that are engaged in technology, contract research services and providers of discovery technologies. The global list of companies covers addresses, contact numbers and the website addresses of 186 companies.

Key Topics Covered:

PART A: GLOBAL MARKET PERSPECTIVE


1. INTRODUCTION
2. KEY MARKET TRENDS
3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE
4. KEY GLOBAL PLAYERS
5. KEY BUSINESS TRENDS
6. GLOBAL MARKET OVERVIEW

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW
1. THE UNITED STATES
2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

PART C: GUIDE TO THE INDUSTRY
1. NORTH AMERICA
2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

PART D: ANNEXURE
1. RESEARCH METHOLOGY
2. FEEDBACK

Companies Mentioned:

  • 4-Antibody AG
  • Abbott Laboratories
  • Accelrys, Inc.
  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Asahi Kasei Pharma Corporation
  • Astrazeneca Plc
  • Aviva Biosciences Corp.
  • BD Biosciences
  • Bayer Healthcare AG
  • Beckman Coulter Inc.
  • Biacore International AB
  • Bio-Rad Laboratories, Inc.
  • Bioanalytical Systems, Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Caliper Life Sciences, Inc.
  • Caprion Proteomics, Inc.
  • Celera Corporation
  • Celgene Corporation
  • Charles River Laboratories International, Inc.
  • Compugen Ltd.
  • Decode Genetics, Inc.
  • EMD Millipore Corporation
  • Evotec AG
  • GE Healthcare Ltd.
  • Genedata AG
  • Hitgen Ltd
  • Hudson Robotics, Inc.
  • Illumina Inc.
  • Incyte Corporation
  • Isis Pharmaceuticals, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Luminex Corporation
  • Maxcyte, Inc
  • Merck & Co., Inc.
  • Millennium Pharmaceuticals, Inc.
  • Molecular Devices, LLC
  • Molecular Discovery Ltd.
  • Molecular Discovery Systems Pty., Ltd.
  • New England Biolabs, Inc.
  • Novartis AG
  • Osiris Therapeutics Inc.
  • Perkinelmer, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Quantum Pharmaceuticals
  • Roche Holding AG
  • Shimadzu Corporation
  • Sigma-Aldrich Corporation
  • Sri Biosciences
  • Tecan Group Ltd.
  • The National Center for Drug Screening
  • Thermo Fisher Scientific Inc.
  • Viva Biotech Ltd
  • Waters Corp.

For more information visit http://www.researchandmarkets.com/research/7zf7hj/drug_discovery

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.